Welcome to our dedicated page for InfuSystem Holdings news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on InfuSystem Holdings stock.
InfuSystem Holdings, Inc. provides health care services that facilitate outpatient care for durable medical equipment manufacturers and health care providers. News for INFU commonly covers financial results, segment trends and operating updates across Patient Services and Device Solutions, including oncology, pain management, wound therapy, direct payer rentals, pump and consumable sales, and biomedical services and repair.
Company updates also address revenue cycle management, payer-network and billing efficiency initiatives, relationships with DME manufacturers, contract economics, margin performance, cash flow, guidance and management presentations at investor conferences.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
InfuSystem Holdings, Inc. (NYSE American: INFU) announced a national distribution agreement with Genadyne Biotechnologies, enhancing its portfolio in negative pressure wound therapy (NPWT). InfuSystem will distribute Genadyne’s complete line of wound care products, including the advanced XLR8 Plus NPWT Pump and XLR8 Dressing Kit with Silver. This partnership aims to address supply chain challenges and provide diverse wound care solutions, ultimately improving patient outcomes and reducing healthcare costs. InfuSystem emphasizes its commitment to facilitating outpatient care and enhancing service delivery in the durable medical equipment sector.